Inventor
STORTELERS CATELIJNE
BE22 patents
⚠️ This page may combine multiple inventors who share the name “STORTELERS CATELIJNE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ABLYNX NV
15 patentsUS9803001B2Oct 31, 2017
Monovalent, bivalent and trivalent anti human respiratory syncytial virus (hRSV) nanobody constructs for the prevention and/or treatment of respiratory tract infections
ABLYNX NV4 citations84
US10550174B2Feb 4, 2020
Amino acid sequences directed against envelope proteins of a virus and polypeptides comprising the same for the treatment of viral diseases
ABLYNX NV6 citations82
US9834595B2Dec 5, 2017
Amino acid sequences directed against envelope proteins of a virus and polypeptides comprising the same for the treatment of viral diseases
ABLYNX NV6 citations82
US10273305B2Apr 30, 2019
Bispecific CXCR4-CD4 polypeptides with potent anti-HIV activity
ABLYNX NV2 citations69
US11028151B2Jun 8, 2021
Monovalent, bivalent and trivalent anti human respiratory syncytial virus (HRSV) nanobody constructs for the prevention and/or treatment of respiratory tract infections
ABLYNX NV0 citations62
US11518799B2Dec 6, 2022
Amino acid sequences directed against envelope proteins of a virus and polypeptides comprising the same for the treatment of viral diseases
ABLYNX NV0 citations61
US11046773B2Jun 29, 2021
Bispecific CXCR4-CD4 polypeptides with potent anti-HIV activity
ABLYNX NV0 citations59
US11840569B2Dec 12, 2023
T cell recruiting polypeptides capable of binding CD123 and TCR alpha/beta
ABLYNX NV1 citations56
US9758584B2Sep 12, 2017
Biological materials related to CXCR7
ABLYNX NV0 citations49
US10023633B2Jul 17, 2018
Method for generation of immunoglobulin sequences
ABLYNX NV1 citations48
US10544216B2Jan 28, 2020
P2X7 receptor antagonists and agonists
ABLYNX NV0 citations47
US9908935B2Mar 6, 2018
P2X7 receptor antagonists and agonists
ABLYNX NV1 citations47
US10875918B2Dec 29, 2020
P2X7 receptor binders and polypeptides comprising the same
ABLYNX NV0 citations41
US9994639B2Jun 12, 2018
Biological materials related to CXCR7
ABLYNX NV0 citations39
US9512236B2Dec 6, 2016
Amino acid sequences directed against GPCRS and polypeptides comprising the same for the treatment of GPCR-related diseases and disorders
ABLYNX NV0 citations38
DEPLA ERIK
2 patentsUS8945567B2Feb 3, 2015
Monovalent, bivalent and trivalent anti human respiratory syncytial virus (HRSV) nanobody constructs for the prevention and/or treatment of respiratory tract infections
DEPLA ERIK8 citations82
US9644022B2May 9, 2017
Amino acid sequences directed against human respiratory syncytial virus (HRSV) and polypeptides comprising the same for the prevention and/or treatment of respiratory tract infections
DEPLA ERIK4 citations71